Skip to main
KTRA

Kintara Therapeutics (KTRA) Market Capitalization Overview

Market Cap: $45.77M as of Jan 9, 2026

$45.77M
$7.29M (13.74%)past month
As of Jan 9, 2026, Kintara Therapeutics (KTRA) has a market capitalization of $45.77M. Over the past 30 days, its market cap has decreased by -51.75%, while in the last 12 months, it has decreased by -0.4%.

Market capitalization represents the total value of Kintara Therapeutics as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

Kintara Therapeutics (KTRA) Market Cap Formula = Stock Price * Shares Outstanding

The market cap of Kintara Therapeutics (KTRA) helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Kintara Therapeutics (KTRA) Market Cap History

DateMarket CapChange
Dec 1, 2025$94.32M-27.34%
Nov 3, 2025$129.81M+2.11%
Oct 1, 2025$127.12M-1.93%
Sep 2, 2025$129.63M+16.03%
Aug 1, 2025$111.72M+3.55%
Jul 1, 2025$107.90M-20.83%
Jun 2, 2025$136.29M-20.00%
May 1, 2025$170.36M+38.44%
Apr 1, 2025$123.05M+34.72%
Mar 3, 2025$91.34M-55.46%
Feb 3, 2025$205.08M+18.00%
Jan 2, 2025$173.79M-25.81%

Kintara Therapeutics (KTRA) End of Year Market Cap History

DateMarket CapChange
2026$45.77M-0.40%
2025$45.95M-73.43%
2024$172.95M+116,674.88%
2023$148.10K-97.34%
2022$5.57M-55.45%
2021$12.50M

FAQs About Kintara Therapeutics (KTRA) Market Cap

As of Jan 9, 2026, the market capitalization of Kintara Therapeutics (KTRA) is $45.77M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Kintara Therapeutics’s market capitalization has decreased by -13.74%, changing from $53.06M to $45.77M as of Jan 9, 2026.

In the last 3 months, Kintara Therapeutics’s market capitalization has increased by —, changing from – to – as of –.

In the year 2025, Kintara Therapeutics’s market capitalization decreased from $172.95M in January to $45.95M in December, reflecting a -73.43% change.

In the past five years, Kintara Therapeutics (KTRA) has had a compound annual growth rate (CAGR) of 29.74% in market capitalization. This means its market cap has grown at an average rate of 29.74% per year.

Kintara Therapeutics (KTRA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.